GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost lymphoma treatment
Disease control OngoingThis early-phase study tests whether adding the drug acalabrutinib to CAR T-cell therapy (axicabtagene ciloleucel) is safe and works better for people with certain B-cell lymphomas. About 23 adults whose lymphoma has returned or not responded to prior treatment will receive the c…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 04:35 UTC
-
New drug cocktail shows promise for follicular lymphoma patients
Disease control OngoingThis study tests a combination of three drugs (obinutuzumab, ibrutinib, and venetoclax) in 40 people with untreated follicular lymphoma. The goal is to see if the combination works better than each drug alone at shrinking tumors. Participants receive the drugs and are monitored f…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Apr 29, 2026 04:29 UTC
-
New drug cocktail shows promise for tough lymphoma cases
Disease control OngoingThis early-phase study tests a combination of three drugs (obinutuzumab, venetoclax, and lenalidomide) in 22 adults with B-cell non-Hodgkin lymphoma that has come back or stopped responding to prior treatments. The main goal is to find the safest dose and identify side effects. R…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: Beth Christian • Aim: Disease control
Last updated Apr 29, 2026 04:27 UTC